Skip to Content

  • Search

View Additional Section Content

A Multicenter, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group, Dose-Ranging Study to Evaluate the Safety and Efficacy of Intravenous Natalizumab (BG00002) in Acute Ischemic Stroke

For more information on this trial, click the link below.

https://clinicaltrials.gov/ct2/show/NCT02730455?term=biogen+action&rank=1

Clinical Trial Categories

  • Stroke Research
Contact
Karin Jonczak, CRNP, CNRN at 215-481-5373

Location

  • The Diamond Stroke Center at Abington Hospital

Find a Physician
Search Our Directory

215-481-MEDI

Schedule a
Test

215-481-EXAM

Clinical Trials Details